FLEX Vessel Prep 12 Month AV Registry Data and 12 Month Belong PAD Data Shows Benefit to Micro-incisions Before Balloon or DCB Treatment

/PRNewswire/ -- VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel...

Related Keywords

New York ,United States ,Fribourg ,Switzerland ,Beth Israel Medical Center ,Orangeburg ,John Aruny ,Kathy Leith ,Johne Aruny ,Eric Secemsky ,Erica Secemsky ,Dialysis Access Institute ,Venturemed Group ,Beth Israel Deaconess Medical Center ,Prnewswire Venturemed Group Inc ,Drug Administration ,Single Center ,Smith Center ,Vascular Research Richard ,Professor Of Medicine Harvard Medical School ,Venturemed Group Inc ,Vascular Intervention Beth Israel Deaconess Medical Center ,Vmed Group ,Month Study ,Access Institute ,Primary Investigator ,Clinical Study ,Late Breaking Trial ,Month Results With Fempop ,Belong Study ,Vascular Intervention ,Interventional Cardiology ,Vascular Research ,Outcomes Research ,Harvard Medical ,Beth Israel Deaconess Medical ,Efficacy Results ,Freedom From ,Freedom From Target Lesion Restenosis ,Freedom From Major ,